Laser Skin Treatment Denied by Insurance? How to Appeal

Laser and light-based skin treatments occupy a gray zone in insurance coverage — some are clearly cosmetic, others are clearly medical, and many fall in between. Insurance companies exploit this ambiguity to deny coverage for treatments that are genuinely medically necessary. Whether your claim involves a port wine stain, hemangioma, keloid, wart, acne scar, or photodynamic therapy (PDT) for actinic keratosis, here is how to build a winning appeal.

Port Wine Stains: The Strongest Medical Necessity Case

Port wine stains (PWS) — congenital vascular malformations — represent the clearest case for laser treatment coverage. The pulsed dye laser (PDL) is the established treatment, and coverage has been supported by courts and state insurance regulations.

Medical necessity arguments for PWS laser treatment:

• Sturge-Weber syndrome: PWS of the face is associated with Sturge-Weber syndrome (leptomeningeal angioma, glaucoma risk). Document neurological and ophthalmological co-management.
• Progressive darkening and thickening: Untreated PWS darken and develop surface nodularity over time, increasing functional impairment. Document natural history.
• Functional impairment: PWS over the eyelid can cause amblyopia (vision loss) in children. Document ophthalmology consultation and visual acuity measurements.
• Psychosocial impact: In children, facial PWS causes significant social and developmental harm. Many state insurance regulations specifically mandate coverage of PWS in children.

Document: PWS size (cm), anatomic location, Fitzpatrick skin type, prior treatment response, and any associated symptoms or complications.

Hemangiomas: Infantile vs. Adult

Infantile hemangiomas (IH): Appear in the first weeks of life and can grow rapidly. Laser treatment is indicated for:

• Hemangiomas causing visual obstruction (periorbital location)
• Airway hemangiomas
• Ulcerated IH with pain or bleeding
• Large facial hemangiomas causing disfigurement

Document: lesion size, growth rate, anatomic location relative to critical structures, any ulceration or functional compromise. Reference AAD guidelines on IH management.

Keloid Treatment: Functional Impairment Is the Key

Keloids form from exaggerated scar tissue and can cause pain, pruritis, restricted range of motion, and psychological distress. Laser treatment for keloids is typically denied as cosmetic, but medical necessity can be established when:

• Keloid restricts range of motion (e.g., over a joint)
• Keloid causes chronic pain or pruritus requiring narcotic or antihistamine management
• Keloid is the result of a medically necessary surgery (post-surgical keloid)
• Keloid is on a pressure point causing recurrent skin breakdown

Document: location, size, duration, symptoms (pain scale, sleep disturbance), functional limitation, and prior treatment failures (corticosteroid injections, silicone sheets, compression therapy).

Wart Treatment with Laser

Laser ablation of warts is appropriate when standard treatments fail. For insurance appeals:

• Document prior treatment attempts: cryotherapy, salicylic acid, cantharidin, immunotherapy (Candida antigen injection)
• Note number of treatment sessions attempted
• For plantar warts: document pain with ambulation using a pain scale, any gait alteration, and impact on work or daily activities
• For periungual warts: document nail damage or pain with nail-bearing activities

Acne Scar Treatment: Reconstructive vs. Cosmetic

Laser resurfacing for acne scars can be medically necessary when scarring causes functional impairment — but documentation must clearly distinguish from purely cosmetic treatment:

• Contracture scars impairing facial expression or perioral movement
• Scars over joints limiting range of motion
• Psychological impairment meeting clinical thresholds (DLQI, PHQ-9)
• Documentation that scars resulted from severe inflammatory acne, a recognized medical condition

Photodynamic Therapy (PDT) for Actinic Keratosis

PDT with aminolevulinic acid (Levulan) and blue light (BLU-U) is FDA-approved and covered for actinic keratosis (AK). Common denial issues:

• Field therapy vs. single lesion: PDT treats a field of multiple AKs simultaneously — document the number of AKs in the treatment field and the field therapy rationale
• Coding: AK PDT is coded under CPT 96567 (photodynamic therapy) and CPT 96570/96571 (additional exposure areas). Document correctly to avoid coding-based denials.
• Frequency: Some insurers limit PDT to once per year per site. If more frequent treatment is needed, document rapid AK recurrence and risk progression to invasive SCC.

Fight Back With ClaimBack

ClaimBack's dermatology appeal platform includes laser and PDT documentation frameworks, cosmetic-to-medical conversion templates, and AAD guideline citations for all skin laser indications.

Start your free appeal at ClaimBack

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Common Reasons Insurance Claims Are Denied